- Argentina
- Australia
- Austria
- Bangladesh
- Belgium
- Botswana
- Brazil
- Bulgaria
- Canada
- Chile
- China
- Colombia
- Cuba
- Czech Republic
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Germany
- Ghana
- Greece
- Hong Kong
- Hungary
- India
- Indonesia
- Ireland
- Israel
- Italy
- Japan
- Kenya
- Latvia
- Lebanon
- Lithuania
- Malaysia
- Mexico
- Morocco
- Namibia
- Netherlands
- New Zealand
- Nigeria
- Norway
- Pakistan
- Peru
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Saudi Arabia
- Senegal
- Singapore
- Slovakia
- Slovenia
- South Africa
- South Korea
- Spain
- Sweden
- Switzerland
- Taiwan
- Tanzania
- Thailand
- Turkey
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- United States
- Venezuela
- Vietnam
- Zimbabwe
Switzerland Health News API
Get the live top health headlines from Switzerland with our JSON API.
Get API key for the Switzerland Health News APIAPI Demonstration
This example demonstrates the HTTP request to make and the JSON response you will receive when you use the news api to get the top headlines from Switzerland.
GET
https://gnews.io/api/v4/top-headlines?country=ch&category=health&apikey=API_KEY
{
"totalArticles": 104544,
"articles": [
{
"id": "4006d6bca234f29c1a16a3704527ed21",
"title": "Celosia Therapeutics Announces First Patient Dosed in Phase 1b Clinical Trial of CTx1000 in Amyotrophic Lateral Sclerosis",
"description": "CTx1000 designed to clear pathological TDP-43 protein, a central driver of ALS SYDNEY, March 23, 2026 /PRNewswire/ -- Celosia Therapeutics, an Australian biotech company developing advanced",
"content": "CTx1000 designed to clear pathological TDP-43 protein, a central driver of ALS\nSYDNEY, March 23, 2026 /PRNewswire/ -- Celosia Therapeutics, an Australian biotech company developing advanced gene therapies for neurodegenerative diseases, today announc... [2578 chars]",
"url": "https://www.finanznachrichten.de/nachrichten-2026-03/68016212-celosia-therapeutics-announces-first-patient-dosed-in-phase-1b-clinical-trial-of-ctx1000-in-amyotrophic-lateral-sclerosis-008.htm",
"image": "https://www.finanznachrichten.de/content/g/fb.png",
"publishedAt": "2026-03-23T21:36:00Z",
"lang": "en",
"source": {
"id": "b388974caf8e8cac86c136456491b6c6",
"name": "FinanzNachrichten.de",
"url": "https://www.finanznachrichten.de"
}
},
{
"id": "e41d86e01b90542e683e01629b4095a7",
"title": "Chabottes Une plongée au cœur du cerveau",
"description": "Vendredi 20 mars, la médiathèque de Chabottes a accueilli une trentaine de personnes pour la conférence diaporama consacrée au cerveau, organisée ...",
"content": "Le Dauphiné Libéré, en tant que responsable de traitement, recueille dans ce formulaire des informations qui sont enregistrées dans un fichier informatisé par son Service Relations Clients, la finalité étant d’assurer la création et la gestion de vot... [767 chars]",
"url": "https://www.ledauphine.com/science-et-technologie/2026/03/23/une-plongee-au-coeur-du-cerveau",
"image": "https://cdn-s-www.ledauphine.com/images/FE78832A-C795-4989-A721-20ED49E85CA1/FB1200/photo-1774290956.jpg",
"publishedAt": "2026-03-23T18:36:04Z",
"lang": "fr",
"source": {
"id": "db97864a4fde6c0864e54a48ace0bc91",
"name": "Le Dauphiné Libéré",
"url": "https://www.ledauphine.com"
}
},
{
"id": "c37b1cee7e8674ce360c2aa871fd9d42",
"title": "Superager: Neue Erkenntnisse zur Neurogenese im Alter",
"description": "Superager bilden im Alter doppelt so viele Neuronen wie Gleichaltrige. Diese Entdeckung könnte den Kampf gegen Demenz revolutionieren.",
"content": "CHICAGO / LONDON (IT BOLTWISE) – Neue Forschungsergebnisse zeigen, dass sogenannte Superager im hohen Alter doppelt so viele neue Nervenzellen bilden wie ihre Altersgenossen. Diese Entdeckung könnte den Kampf gegen Demenz revolutionieren und neue Weg... [2615 chars]",
"url": "https://www.it-boltwise.de/superager-neue-erkenntnisse-zur-neurogenese-im-alter.html",
"image": "https://www.it-boltwise.de/wp-content/uploads/2026/03/ai-superager-neurogenesis.jpg",
"publishedAt": "2026-03-23T18:36:01Z",
"lang": "de",
"source": {
"id": "0b457712d5f851f85469a0f9f6a4fae8",
"name": "it-boltwise.de",
"url": "https://www.it-boltwise.de"
}
}
]
}